Financing ·
On September 11, 2026, Park Ha Biological Technology Co., Ltd. closed a private investment in public equity (PIPE)…
BYAHPark Ha Biological Technology Co., Ltd.
On September 11, 2026, Park Ha Biological Technology Co., Ltd. closed a private investment in public equity (PIPE) transaction with non-U.S. investors. The company issued and sold 1,845,452 Class A ordinary shares at $2.75 per share, generating aggregate gross proceeds of approximately US$2,970,000 before offering expenses. Concurrently, the purchasers received warrants to buy an additional 1,845,452 Class A ordinary shares, exercisable immediately at $1.10 per share with a five-year term and a conversion ratio of two-and-a-half shares per warrant. The net proceeds are intended for general working capital and corporate purposes. Park Ha Biological Technology Co., Ltd. operates in the biotechnology industry, focusing on biological technology development.